SCHEDULE: Evogene Ltd. Stakeholder Increases Holding

L.I.A. Pure Capital Ltd. and associated entities have amended their Schedule 13D filing to report an increase in their beneficial ownership of Evogene Ltd. ordinary shares and ADSs.

Summary

• L.I.A. Pure Capital Ltd. (Pure Capital) and associated entities have filed an amendment (Amendment No. 4) to their Schedule 13D, reporting increased beneficial ownership in Evogene Ltd.
• The filing indicates that Pure Capital acquired an additional 533,088 American Depositary Shares (ADSs) using working capital.
• As of the filing date, the reporting persons collectively beneficially own 3,057,488 ADSs and Ordinary Shares, representing approximately 19.35% of Evogene's outstanding share capital.
• This ownership stake is based on 15,801,407 Ordinary Shares outstanding as of July 27, 2026, as per Evogene's Proxy Statement.
• Kfir Silberman is the officer, sole director, chairman, and controlling shareholder of Pure Capital.
• Invest Pro Shukai Hon Ltd. (Invest Pro) holds 500,000 ADSs, with Ron Yair Peled as its owner and CEO.
• Voting power for a significant portion of the reported securities is shared under an oral agreement.
• The reporting persons may be considered a 'group' for Section 13(d) purposes, though they disclaim the existence of such a group.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative sentiment due to the increased stake by a known investor, which could signal a lack of confidence from other shareholders or a strategic move by the investor without immediate positive news for the company itself.

Positives

• Increased stake by a significant investor (L.I.A. Pure Capital Ltd.) may indicate confidence in the company's long-term prospects.
• The acquisitions were made in the open market, suggesting a strategic accumulation of shares.

Negatives

• The filing is an amendment to a Schedule 13D, indicating a change in beneficial ownership that could be perceived as a shift in control or influence.
• The aggregate beneficial ownership of 19.35% by a single group could raise concerns among other shareholders about potential influence or future actions.
• The specific details of the oral voting agreement are not fully disclosed, creating some opacity.

Risks

• Potential for increased influence or control by the reporting persons over Evogene's strategic decisions.
• The formation of a 'group' for Section 13(d) purposes, even if disclaimed, could lead to increased regulatory scrutiny or market speculation.
• Lack of full transparency regarding the oral voting agreement could pose a risk to minority shareholders.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from Evogene Ltd. It primarily reports on changes in beneficial ownership by certain investors.

Management Comments

• "The filing of this Schedule 13D shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), the beneficial owners of any securities of the Issuer he or it does not directly own."
• "Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein."
• "Neither the filing of this Schedule 13D nor any of its contents shall be deemed to constitute an admission that a group exists for purposes of Schedule 13(d) of the Exchange Act or for any other purpose, and each Reporting Person disclaims the existence of any such group."

Industry Context

StockSavvy.ai notes that Schedule 13D filings are common in the biotechnology and agricultural technology sectors, where significant investments and potential strategic shifts can occur. The increased stake by L.I.A. Pure Capital Ltd. in Evogene, a company focused on gene editing and agricultural solutions, aligns with typical investor activity in this space.

Stakeholder Impact

• Shareholders: May experience increased volatility or speculation due to the significant stake held by L.I.A. Pure Capital Ltd. and the potential for future influence on corporate strategy.
• Management: May face increased scrutiny or pressure from the reporting persons regarding company performance and strategic direction.
• Potential Investors: May view the increased stake as a signal of either confidence or potential future activism, influencing their investment decisions.

Next Steps

• Continued monitoring of L.I.A. Pure Capital Ltd.'s beneficial ownership and any further amendments to the Schedule 13D.
• Observation of any potential strategic actions or communications from the reporting persons regarding Evogene Ltd.

Key Dates

Recommendation

The filing indicates a significant increase in beneficial ownership by L.I.A. Pure Capital Ltd., which is a substantial stake (19.35%). While this could signal confidence, it also introduces potential for increased influence or activism, creating uncertainty. Without further information on the investor's intentions or company performance, a 'hold' position is prudent, allowing for observation of future developments.

Keywords

Evogene Ltd., Schedule 13D, L.I.A. Pure Capital Ltd., Kfir Silberman, American Depositary Shares, Ordinary Shares, Beneficial Ownership, Shareholder